Your gut microbes produce chemicals called metabolites that might influence cancer. Some of these chemicals push cancer forward by causing chronic inflammation, damaging DNA, and sending signals that help tumors grow. Other metabolites work in the opposite direction. They help stop cancer from spreading by calming the immune system, triggering cell death in bad cells, and changing how genes work. This review looked at how these substances affect several types of cancer including colorectal, pancreatic, breast, liver, head and neck, and blood cancers. The findings suggest these chemicals play a big role in whether a tumor grows or stays under control. However, the science is not settled yet. We do not know for sure if these chemicals cause cancer directly or if they just make it worse. More research is needed to confirm these links and to understand exactly how they work. Until then, these metabolites remain an important area of study but are not yet ready to be used as a standard treatment. They could one day help doctors predict how a patient will respond to chemotherapy or immunotherapy, but that is still a future possibility.
Microbial metabolites may drive cancer growth or stop it through inflammation and DNA damage
Photo by Brett Jordan / Unsplash
What this means for you:
Microbial metabolites can promote or suppress cancer, but we need more proof before using them as treatment. More on Cancer
cGAS–STING activation correlates with improved survival and enhanced checkpoint blockade response in cancer Activating a cancer-fighting immune pathway can help tumors shrink but too much may backfire
Frontiers · Jun 3, 2026
Systematic review and meta-analysis of ML with cfDNA for cancer detection across stages Simple blood test spots early cancer without scary scans
· May 15, 2026
Preclinical deep learning framework shows improved dose prediction for unseen cancer sites A Heavy Burden on Doctors
medRxiv · Apr 24, 2026
Phase III trial indicates ultra-low-dose nivolumab may improve survival over chemotherapy in advanced solid tumors A Tiny Dose of This Cancer Drug Is Outperforming Chemo
· Apr 23, 2026